Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Heart-healthy habits keep you biologically young, study shows May 29, 2024 Novel mucosal vaccine offers broad protection against diverse influenza viruses April 3, 2026 Nigeria first to rollout new Men5CV vaccine against meningitis April 15, 2024